Product logins

Find logins to all Clarivate products below.


Peripheral Vascular Devices | Market Insights | Japan | 2022

The continuing emergence of data supporting the safety of paclitaxel-coated devices will drive growing adoption of premium-priced DES and DCBs, supporting modest growth overall in the Japanese PV device market through 2030. Market revenues will be hindered by the impact of COVID-19 pandemic in the short term and by ASP declines caused by biennial reimbursement cuts by the MHLW over the forecast period.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for PV devices in Japan across an 11-year period.

Related Medtech Insights Reports

Report
Diagnostic Imaging Systems – Market Insights – Japan
Japan’s diagnostic imaging system market will experience slow growth through 2034, driven by continuous technological advancement and rising hospital demand for efficient, patient-centric imaging…
Report
Laparoscopic Devices – Market Insights – Japan
The Japanese laparoscopic device market will expand modestly through 2034, driven by rising demand for MIS procedures among the country’s rapidly aging population. Additionally, the adoption of…
Report
Urological Devices – Market Insights – Japan
The Japanese urological device market will continue to expand through 2034, driven by the rising prevalence of risk factors for urological disorders, such as the growing burden of metabolic…
Report
Peripheral Vascular Devices – Market Insights – Europe
The European PV device market will be mainly driven by the increasing availability of premium-priced products and emerging products which, supported by clinical data, will increase the penetration…
Report
Peripheral Vascular Devices – Market Insights – United States
The US PV device market will be primarily driven by product innovation, novel technologies, and adoption of premium solutions. However, barriers such as the push for cost-effective PV interventions…